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WAP-T1 transgenic mice express SV40-TAg under control of the whey acidic protein (WAP)
promoter, which directs activity of this strong viral oncogene to luminal cells of the mam-
mary gland. Resting uniparous WAP-T1 glands develop hyperplasia composed of TAg
positive cells prior to appearance of advanced tumor stages. We show that cells in hyper-
plasia display markers of alveolar differentiation, suggesting thatTAg targets differentiating
cells of the alveolar compartment.The glands show significant expression of Elf5 and milk
genes (Lalba, Csn2, and Wap).TAg expressing cells largely co-stain with antibodies to Elf5,
lack the epithelial marker Sca1, and are hormone receptor negative. High expression levels
of Elf5 but not of milk genes are also seen in resting glands of normal BALB/c mice. This
indicates that expression of Elf5 in restingWAP-T1 glands is not specifically induced byTAg.
CK6a positive luminal cells lackTAg.These cells co-express the markers prominin-1, CK6a,
and Sca1, and are positive for hormone receptors.These hormone sensitive cells localize to
ducts and seem not to be targeted byTAg. Despite reaching an advanced stage in alveolar
differentiation, the cells in hyperplasia do not exit the cell cycle. Thus, expression of TAg
in conjunction with regular morphogenetic processes of alveologenesis seem to provide
the basis for a hormone independent, unscheduled proliferation of differentiating cells in
resting glands of WAP-T1 transgenic mice, leading to the formation of hyperplastic lesions.
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INTRODUCTION
Breast cancer, a progressive disease of mammary gland epithe-
lia, is marked by consecutive appearance of different alterations,
namely hyperplastic lesions, carcinoma in situ, and invasive, malig-
nant adenocarcinomas. The mutational signature of human breast
cancer supports the view of a direct evolutionary relationship
between pre-neoplastic and malignant lesions (1–5). Mutations
that inactivate functions of tumor suppressor proteins and thereby
decrease genomic stability seem to be basic to initiation of breast
cancer. Transgenic mouse strains were developed to mimic this
process at an experimental level and to decipher the mechanisms
initiating breast cancer and promoting progression to malignant
stages. Major questions concern the cell types targeted by onco-
genes in these models as this might determine the phenotype of
tumor cells appearing at advanced stages. Here, we asked whether
non-malignant, hyperplastic lesions appearing in resting glands of
WAP-T1 transgenic mice (6) reflect selection of a distinct epithelial
cell type or whether these lesions already display a heterogeneous
cell composition as is seen in advanced tumor stages.
WAP-T1 mice express SV40-T-antigen (TAg) under control of
the whey acidic protein (WAP) promoter, which directs activity
Abbreviations: CSN2, casein; ER, estrogen receptor; IF, immunofluorescence;
LALBA, lactalbumin; n.s., not significant; PR, progesterone receptor; SV40, Simian
virus 40; Tag, T-antigen; WAP, whey acidic protein.
of this strong viral oncogene specifically to epithelial cells of the
gland. The transgene encodes both, the large (LT) and small (t)
T-antigen. They cooperate to inactivate the tumor suppressor pro-
teins RB and p53, alter expression of cell cycle regulating genes,
promote unscheduled transition through G1/S, and impair DNA-
damage response mechanisms, events that are known to decrease
genomic stability (7–9).
The WAP promoter responds to lactotrophic hormones and
thus is inactive in glands of virgin mice, active during lactation in
differentiated luminal epithelial cells of the lobulo-alveolar com-
plex, and at a lower level also active in the resting gland during
estrous cycle (10–14). In accordance, epithelial cells of glands in
virgin mice lack TAg whereas differentiated epithelial cells of the
lactating gland show high levels of this protein. TAg positive cells
of the lactating gland disappear with regression of lobulo-alveolar
structures during involution (15–17). Sections of resting glands
derived from uniparous mice show re-appearance of T-antigen
positive epithelial cells at about 30 days post-weaning (p.w.). They
constitute small hyperplastic lesions, which gradually increase in
size and completely pervade the gland at 100 days p.w. Similar
to human breast cancer, these hyperplastic lesions develop prior
to appearance of carcinoma in situ and advanced tumor stages
WAP-T1 (2–6). Malignant tumors develop late at low frequency in
glands of WAP-T1 mice. They reveal a gene expression profile that
recapitulates the phenotype of aggressive human cancers (18).
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The data suggest that carcinogenesis in resting glands of WAP-
T1 is largely delayed or halted at the stage of hyperplastic lesions.
The cellular composition of hyperplasia and the status of TAg
expressing epithelial cells in these lesions compared to lactating
glands and advanced tumor stages are not defined. It was spec-
ulated that TAg expression in WAP-T1 selects for certain epithe-
lial cell types. A gene expression analysis showed that WAP-T1
tumor samples are enriched in transcription factors relevant for
embryonic stem cell maintenance. It led one to assume that TAg
expression may favor survival and proliferation of cells displaying
features of epithelial stem or progenitor cells (19). But not only
stem or progenitor cells but also cells at advanced stages of differ-
entiation have been proposed to generate hyperplastic lesions in
transgenic mouse models (20–24).
Epithelia of the mouse mammary gland reveal a complex com-
position, marked by stem and progenitor cells, terminally differ-
entiated cells, and regulatory units, such as hormone sensing cells
(25). They rapidly change composition and functional status of the
layer in dependence of developmental stages and environmental
signals. This raises the question whether oncogenic activity of TAg
in WAP-T1 mice at the early stage of hyperplasia randomly targets
epithelial cells or promotes selection of a distinct cell type. Gene
expression analysis of advanced WAP-T1 tumors identified at least
two different tumor entities, which completely differ in marker
expression: (i) low grade tumors, exhibiting a basal-like and mor-
phologically differentiated phenotype with loss of chromosomes
2 and 19 and (ii) high grade tumors marked by strong expression
of the Met gene and by co-expression of keratin 8/18, keratin 6,
and the mesenchymal marker vimentin (26). But, a heterogeneous
cell composition of advanced tumors does not necessarily contra-
dict the idea that TAg selects for a distinct epithelial cell type.
Data obtained with a tumor cell line derived from WAP-T1 glands
showed that tumor cells are equipped with phenotypic plasticity,
which for instance allows these cells to acquire a mesenchymal
or an epithelial phenotype depending on the tumor environment
(27).
Our data show that hyperplasia in resting glands of WAP-T1
mice are uniformly composed of cells differentiating along the
alveolar lineage. The results suggest that expression of the viral
oncogene in luminal epithelial cells pre-disposed to alveologene-
sis induces unscheduled proliferation of differentiating cells and
thereby causes formation of hyperplasia.
MATERIALS AND METHODS
MICE
Inbred BALB/c and the transgenic WAP-SV40 early region mouse
line T1 (6) were housed under SPF conditions in accordance
with official regulations for care and use of laboratory animals
(UKCCCR Guidelines for the Welfare of Animals in Experimental
Neoplasia) and approved by Hamburg’s Authority for Health (Nr.
24/96).
PREPARATION OF MOUSE MAMMARY GLANDS AND ISOLATION OF
LUMINAL CELL SUBPOPULATIONS
Mammary glands were collected at indicated time points from
virgin mice, lactating mice, and uniparous mice of the BALB/c or
WAP-T1 strains, respectively. Lymph nodes and tumors sometimes
present at late stages in WAP-T1 mice were removed. Mammary
glands to be used for RNA extraction were snap-frozen in liquid
nitrogen. Glands intended for immunofluorescence were embed-
ded in Shandon Cryomatrix (Thermo Scientific) and frozen at
−80°C. To extract cells for subsequent FACS-sorting all mammary
glands from one mouse were pooled in L15 Medium (Sigma-
Aldrich), transferred to a sterile Petri dish and minced with
scalpels. The organoid suspension was digested in serum-free L15
Medium with 3 mg/ml Collagenase Type I (Life Technologies) and
1.5 mg/ml trypsin (Sigma-Aldrich) for 1 h at 37°C. Cells were col-
lected by centrifugation at 300× g for 5 min and washed once in
L15+ 10% fetal calf serum (FCS). Red blood cells were lysed by
two rounds of incubation with red blood cell lysis buffer (Sigma-
Aldrich) and after two washes with PBS/0.02% EDTA cells were
incubated for 15 min at 37°C in SMEM Medium (Life Technolo-
gies). Cells were collected by centrifugation and incubated for
2 min at 37°C in 2 ml of 0.25% trypsin/0.2% EDTA in HANKS
balanced salt solution (Sigma-Aldrich); Cells were resuspended in
5 ml L15 medium, 400 U/ml Dnase I (Sigma-Aldrich) were added,
and the cells were incubated for another 5 min at 37°C before
the reaction was stopped by addition of 5 ml L15+ 10% FCS. To
obtain a single cell suspension, the cells were passed through a
30µm filter (Miltenyi Biotech). Lineage depletion was performed
using a mouse Lineage Cell Depletion Kit (Miltenyi Biotech),
which selects for CD5, CD45R (B220), CD11b, Gr-1 (Ly-6G/C),
7-4, and Ter-119 positive cells and permits subsequent isolation of
Sca1 positive cells.
FACS-SORTING
After lineage depletion cells extracted from mammary glands
were stained with FITC hamster anti-mouse CD61 (BD Bio-
sciences; 1µg/106 cells), PE hamster anti-mouse/rat CD29 (BioLe-
gend; 0.4µg/106 cells), and AlexaFluor647 rat anti-mouse Ly-6A/E
(Sca1) (BioLegend; 0.5µg/106 cells). Respective isotype controls
were included. The cells were sorted on a FACS Aria (BD Bio-
sciences). After sorting, aliquots of cells for immunofluorescence
were plated on poly-lysine coated cover slips. Cells for RNA
extraction were collected by centrifugation.
Sizes of subpopulations were derived from independent FACS
experiments (BALB/c n= 10; WAP-T1 n= 23). In each experi-
ment, the percentage of total cells was determined for each subpop-
ulation and mean values± SEM were calculated from all experi-
ments. Statistical significance was assessed using Student’s t -test
and p-values<0.05 were considered as statistically significant.
RNA EXTRACTION AND QUANTITATIVE REAL TIME PCR
Total RNA was purified using peqGOLD TriFast (Peqlab) accord-
ing to the manufacturer’s protocol. FACS-sorted cells were lysed
directly in TRIfast, frozen mouse tissue was carefully cut into
small pieces on dry ice, transferred to a lysing matrix tube (MP
Biomedicals), and lysed in TRIfast by two cycles of 5 s in a
FastPrep instrument (MP Biomedicals). DNA was removed by
DNAse I digestion (QIAGEN) followed by another round of RNA
extraction using TRIfast. Reverse transcription was performed
with the High Capacity RT kit (Applied Biosystems) accord-
ing to the manufacturer’s protocol. PCR was performed using
the Power SYBR Green PCR Master Mix (Applied Biosystems)
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in a standard program (10 min 95°C; 15 s 95°C, 1 min 60°C; 40
cycles) running in an ABI 7900HT Fast Thermal Cycler (Applied
Biosystems). PCR reactions for each sample were repeated in trip-
licates. The integrity of the amplified products was confirmed
by melting-curve analysis. PCR primers (Table S1 in Supple-
mentary Material) were designed using the Primer3 web tool
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi). PCR
efficiency was measured for each primer pair using serial dilutions
of cDNA. 18S rRNA or HSC70 were used as endogenous controls
and relative quantitation of transcript levels was performed based
on the 2−ddCt method.
For the gene expression analysis in whole mammary glands
(Figure 5), 10 BALB/c and 10 WAP-T1 mammary glands from
five mice each were analyzed and fold changes relative to a BALB/c
mammary gland were calculated. Mean values and SEM were
calculated from the 10 single values for BALB/c and WAP-T1
mice. Statistical significance was assessed using Student’s t -test
and p-values<0.05 were considered statistically significant.
For the gene expression analysis in sorted subpopulations
(Figures 6C, 7 and 9) data was derived from at least three
independent sorting experiments (Figure 6C: BALB/c and T1
n= 5; Figures 7 and 9: BALB/c n= 4, T1 n= 5, BALB/c vir and
T1 vir n= 3). Fold changes relative to BALB/c subpopulations
(Figure 6C: CD29hi; Figures 7 and 9: CD61+Sca+) were cal-
culated and data from single experiments were summarized as
mean values± SEM. Statistical significance was assessed using Stu-
dent’s t -test and p-values <0.05 were considered as statistically
significant.
IMMUNOHISTOCHEMISTRY
Tissue specimens were fixed overnight with 4% formaldehyde and
1% acetic acid, and stored in 4% formaldehyde at 4°C. Fixed tissue
was embedded in Paraplast X-TRA (Sherwood Medical). Deparaf-
finated sections were stained with H&E (Sigma) according to stan-
dard laboratory protocols. For labeling with antibodies deparaf-
finated sections were treated with an antigen retrieval solution
(Citra Plus, Biogenex). Sections were blocked with normal serum
for 1 h at room temperature and stained with primary antibodies
at appropriate dilutions overnight at 4°C. Bound antibodies were
detected using alkaline phosphatase-, respectively peroxidase-
labeled anti Ig detection systems (Envision, DakoCytomation).
Alkaline phospatase activity was visualized using naphthol AS-BI-
phosphate and New Fuchsin (Fuchsin plus substrate-chromogene,
DakoCytomation) as substrate; peroxidase activity was identified
using diaminobenzidine (DAB) as substrate. Sections were coun-
terstained with hemalum and embedded in Mowiol. Photographs
were taken with a LEICA DMI6000B.
For preparation of cryosections glands embedded in cryoma-
trix were sectioned in a LEICA CM 3050 cryotome at −30°C.
Sections were attached to glass cover slips and stored at −20°C.
Sections attached to glass coverslips were incubated with −20°C
acetone for 10 min, acetone was evaporated at room tempera-
ture for 5 min, and sections were rehydrated in PBS for 10 min
at room temperature. Staining was done at room temperature in
a dark chamber. Sections were blocked with 5% normal serum
for 45 min, incubated with the primary antibody for 1 h, washed
with PBS three times for 10 min each, stained with fluorochrome
labeled secondary antibody for 1 h, and washed again with PBS
three times 10 min each. Nuclei were visualized by counterstaining
with DAPI or DRAQ5. Stained sections were embedded in Mowiol.
Photographs were taken with a Zeiss LSM 501 confocal micro-
scope or with epifluorescence microscopes (LEICA DMI6000B
and LEICA DMRA).
ANTIBODIES
Primary antibodies directed to SV40-TAg were derived from
guinea pig or rabbit. Commercial antibodies used were CK6a
(PRB-169P-100, Covance), CK8/18 (AcrisBP5007), CK14 (Acris
BP5009), Mcm2 (N-19 sc-9839, Santa Cruz), Ki67 (H-300, sc-
15402, Santa Cruz), ELF5 (N-20, sc9645, Santa Cruz), PR (C-18
sc-538, Santa Cruz), ER (M-20 sc542, Santa Cruz), CD 133 (clone
13A4, eBioscience 14-1331-82), Ly-6A/E (Sca1) (BioLegend), and
phospho-histone H3 (Ser10) (Cell Signaling 9701). Antibodies
conjugated with Alexa Fluor dyes (Alexa 488, Alexa 555, Alexa
633) (Molecular Probes) were used as secondary antibodies.
RESULTS
RESTING UNIPAROUS WAP-T1 GLANDS SHOW FEATURES OF
ALVEOLOGENESIS
Immunohistochemical studies performed on paraffin sections of
resting uniparous WAP-T1 glands showed local clusters of TAg
positive luminal epithelial cells in ducts (Figure 1A). These clus-
ters were often associated with processes of side bud formation
(Figure 1B, arrow) Condensing chromatin in individual TAg pos-
itive cells (see Figure 1C, arrows) suggested mitotic activity in these
lesions. Reaction of individual TAg positive cells with antibodies
to phospho-histone H3, a marker of condensing chromosomes in
mitosis, corroborates this suggestion (Figure 1D). The data suggest
that TAg expressing cells are involved in morphogenetic processes
inducing lobulo-alveolar structures.
To characterize TAg positive cells in relation to functional stages
of luminal epithelia we performed an IF double labeling study
with antibodies to Sca1 and SV40-TAg on cryosections of WAP-
T1 glands. Sca1 is a GPI-anchored protein that was originally
identified in hematopoietic stem cells. In the mouse mammary
gland, it was reported to mark luminal epithelial cells in ducts and
bipotent luminal progenitor cells of the lobulo-alveolar compart-
ment, but not terminally differentiated alveolar cells (28–30). In
our labeling study, we included glands from virgin mice, lactating
mice, and uniparous mice (120 days p.w.). As shown in Figure 2A,
luminal epithelia of virgin WAP-T1 glands contained Sca1 posi-
tive and negative cells, but were generally devoid of TAg. Luminal
epithelia of lactating glands were TAg positive but Sca1 nega-
tive (Figure 2B). In similar, cells in hyperplastic lesions of resting
uniparous WAP-T1 glands which stained positively for TAg were
also Sca1 negative (Figures 2C,D). Sca1 positive epithelial cells in
glands were confined to luminal epithelia of ducts and did not stain
with antibodies to TAg. These findings suggest that TAg expression
is confined to Sca1 negative luminal epithelial cells.
To substantiate a relationship of TAg expression with alveolo-
genesis, we assayed resting uniparous WAP-T1 glands (120 days
p.w.) for expression of ELF5, a transcription factor known as mas-
ter regulator of alveologenesis (31). Immunofluorescence staining
on cryosections demonstrated that TAg positive cells co-expressed
www.frontiersin.org June 2014 | Volume 4 | Article 168 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quante et al. Hyperplasia in WAP-T1 mice
FIGURE 1 | SV40-TAg positive epithelial cells cluster at sites of bud
formation. (A–C)TAg labeling on sections of paraffin embedded WAP-T1
glands isolated 60 days post-weaning (p.w.); alkaline phosphatase (A,B) or
peroxidase (C) conjugated antibodies were used as secondary antibodies;
TAg expressing cells cluster at sites of bud formation [arrows in (A,B)];
individual TAg positive epithelial cells show condensing chromatin [arrows in
(C)]; (D) IF double labeling with antibodies to TAg (green) and
phospho-histone H3 (blue) on cryosections of resting uniparous WAP-T1
glands; phospho-histone H3 staining points to mitotic activity in WAP-T1
hyperplastic lesions. Bars: (A)=50µm; (B)=15µm; (C,D)=10µm.
ELF5 (Figure 3). But, expression of TAg and ELF5 in epithelia of
hyperplasia did not totally overlap. A proportion of TAg positive
cells showed only weak staining or was ELF5 negative (Figure 3).
The data suggest that TAg and Sca1 mark different func-
tional entities of cells in luminal epithelia of WAP-T1 glands:
TAg+/Sca1− cells representing the differentiating lobulo-alveolar
compartment, and TAg−/Sca1+ identifying cells of the ductal
epithelium.
To determine whether TAg expressing cells in hyperplasia of
WAP-T1 glands proliferate, we labeled cryosections with antibod-
ies to Mcm2 and to Ki67, both of which are nuclear markers
that are expressed in cycling cells. Mcm2 is a member of the
licensing protein family, which facilitates coordinated transition
from G1 into S-phase and is down-regulated, when cells exit the
cell cycle (32). Human mammary gland epithelia show Mcm2
in nuclei of differentiating but not in terminally differentiated
cells (33). Ki67 is expressed in G1, S, G2, and M-phase of the
cell cycle but is absent from cells resting in G0. Thus, Ki67 is
FIGURE 2 |TAg is expressed in Sca1 negative luminal epithelial cells.
(A,B) IF double labeling with antibodies to Sca1(green) and TAg (red) on
cryosections of WAP-T1 glands; staining of DNA with DAPI (blue);
(A) luminal epithelia in virgin WAP-T1 glands are TAg negative and reveal a
heterogenous Sca1 staining pattern; (B) luminal epithelia in lactating
WAP-T1 glands are TAg positive and Sca1 negative; (C,D)TAg positive cells
in epithelial compartments of resting uniparous WAP-T1 glands (120 days
p.w.) are also Sca1 negative. Bars: (A–C)=50µm; (D)=5µm.
used to identify the proliferating cell compartment in tissue (34).
Hyperplasia in resting uniparous WAP-T1 glands exhibited promi-
nent Mcm2 staining as shown by immunoperoxidase labeling on
paraffin sections (Figure 4A). IF double labeling on cryosections
revealed coincident labeling of TAg and Mcm2 in epithelial cells
(Figure 4B). TAg positive cells also co-stained with antibodies
to Ki67 (Figure 4C). These results indicate that TAg expressing
epithelial cells that accumulate in hyperplasia of resting WAP-T1
glands do not exit the cell cycle.
RESTING UNIPAROUS WAP-T1 GLANDS SHOW LACTOGENIC ACTIVITY
Next, we asked whether formation of lobulo-alveolar structures in
resting WAP-T1 glands correlated with lactogenic activity, which is
marked by expression of the milk genes WAP, Csn2 (beta-casein),
and Lalba (lactalbumin). For comparison, we included in our
analysis one gland from each, a lactating WAP-T1 mouse, a BALB/c
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FIGURE 3 |TAg positive cells in hyperplasia co-stain with antibodies to
ELF5. IF double labeling on cryosections of resting uniparous WAP-T1
glands (120 days p.w.) with antibodies to TAg (green) and ELF5 (red);
staining of DNA with DAPI; individual TAg positive cells lack ELF staining
signal. Bar=50µm.
virgin mouse, and a WAP-T1 virgin mouse. qRT-PCR analysis per-
formed with whole glands (summarized in Figure 5) revealed high
expression levels of ELF5 and milk genes in glands of lactating
WAP-T1 mouse (T1 Lak, Figures 5A–D), and low levels in glands
from virgin mice (T1vir and BALB/c vir, Figures 5A–D). Resting
glands of WAP-T1 (T1 120 pw) showed prominent Elf5 expres-
sion (Figure 5A), clearly exceeding the level in resting BALB/c
glands (BALBc 120 pw, Figure 5A) by 1.7-fold (p< 0.01). Milk
gene expression was detectable in all glands, but showed clear dif-
ferences between WAP-T1 and BALB/c. While Csn2 expression
was only slightly (~twofold, n.s.) upregulated in resting WAP-T1
glands compared to resting BALB/c glands (see BALB/c 120 pw and
T1 120 pw in Figure 5B), Lalba and Wap expression levels were
increased 40- and 10-fold, respectively (p< 0.001 and p< 1.00E-
05) (Figures 5C,D). These data suggest enhanced alveologenesis
in resting uniparous WAP-T1 glands.
TAg EXPRESSING CELLS REACH AN ADVANCED STAGE IN ALVEOLAR
DIFFERENTIATION
Based on our in situ analysis, we asked if we could use Sca1 as
marker to isolate luminal cell populations from WAP-T1 glands
in order to define their status by RT-PCR. Single cell populations
obtained after proteolytic digestion of glands and lineage deple-
tion were fractionated into subpopulations applying fluorescent
activated cell sorting. A first approach, trying to isolate the bulk
of epithelial cells directly by use of CD24 did not reveal clear sub-
populations in samples from WAP-T1 glands. Thus, we selected
CD29 as marker to separate luminal (CD29low) from basal epithe-
lial cell populations (CD29high). The CD29low population was then
fractionated into Sca1+ and Sca1− subpopulations. In addition,
we included CD61 as marker in our sorting strategy (Figure 6A).
CD61 was described to mark luminal progenitor cells, endowed
with the potential to differentiate into alveolar or ductal cells
(35).Our sorting strategy is similar to that previously described
by Shehata et al. (36), who also used Sca1 to isolate luminal cell
subpopulations. But in difference to our approach they isolated
epithelial cells directly by use of Epcam and substituted CD61 for
CD49b.
Sorting yielded four different luminal subpopulations
(Figure 6B), which were assayed for gene expression
by qRT-PCR: the subpopulations CD29low/CD61+/Sca1+
and CD29low/CD61−/Sca1+, which we expected to be
enriched with TAg negative cells, and the subpopulations
CD29low/CD61+/Sca1− and CD29low/CD61−/Sca1−, which we
expected to be enriched with TAg positive cells differentiating
along the alveolar lineage. qRT-PCR (Figure 6C) verified that
cells expressing the myoepithelial marker CK14 clearly separated
with the CD29hi subpopulation. Thus, basal epithelial cells were
separated efficiently from luminal cell subpopulations in this
approach. In accordance, immunofluorescence staining showed
CK14 positive cells only in CD29hi subpopulations (data not
shown). The relative proportion of CD61+ cells in samples iso-
lated from resting glands of BALB/c and WAP-T1 mice was rather
identical (Figure 6D). But compared to BALB/c, the propor-
tion of CD61−/Sca1+ cells was significantly decreased (15.6 vs.
27.9%, p< 0.05) and that of CD61−/Sca1− cells was significantly
increased (54.2 vs. 39.2%, p< 0.05) in WAP-T1 samples. This sug-
gests a relative shift in population sizes to differentiating alveolar
cells in WAP-T1 glands.
qRT-PCR analysis of TAg expression in luminal cell sub-
populations isolated from resting uniparous WAP-T1 glands
(T1 in Figure 7D) showed high and nearly identical levels in
the Sca1 negative subpopulations CD29low/CD61+/Sca1− (fur-
ther named CD61+/Sca1−) and CD29low/CD61−/Sca1− (fur-
ther named CD61−/Sca1−). TAg levels were fourfold lower in
the Sca1 positive subpopulations CD29low/CD61+/Sca1+ (fur-
ther named CD61+/Sca1+) and CD29low/CD61−/Sca1+ (further
named CD61−/Sca1+). Sca1 negative subpopulations from rest-
ing WAP-T1 glands also displayed high expression levels of Elf5,
Wap, and Lalba (T1 in Figures 7A–C). Expression levels of these
genes were significantly lower in Sca1+ subpopulations.
Then, we asked if ELF5 and milk gene expression observed
in Sca− subpopulations from resting WAP-T1 glands (T1 in
Figures 7A–C) is also detectable in luminal cell subpopulations
from resting BALB/c glands. qRT-PCR analysis revealed signifi-
cant expression of Elf5, Lalba, and Wap in Sca1− subpopulations
from BALB/c but only basal expression levels in Sca1+ subpop-
ulations (BALB/c in Figures 7A–C). Remarkably, Elf5 expres-
sion (Figure 7A) in the Sca1−/CD61+ subpopulation reached
the same high level as in WAP-T1, but was decreased 2.5-fold
(p< 0.01) in the Sca1−/CD61− subpopulation compared to WAP-
T1. This indicates that Elf5 expression in differentiating alveolar
cells of BALB/c does not reach the same high level as in WAP-T1.
Overall expression levels of milk genes (Figures 7B,C) in Sca1−
subpopulations from BALB/c were low compared to WAP-T1:
Lalba expression was reduced by ~twofold (n.s.) in CD61+/Sca1−
and ~10-fold (p< 0.01) in CD61−/Sca1− subpopulations; Wap
expression was reduced ~70- and 100-fold (p< 0.05 and p< 0.01),
respectively.
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FIGURE 4 |TAg positive luminal epithelial cells co-stain with
antibodies to proliferation markers. (A) Immunoperoxidase labeling
with Mcm2 antibodies on sections of paraffin embedded resting
uniparous WAP-T1 glands (60 days p.w.) shows strong nuclear
staining of epithelia in hyperplasia; in ductal epithelia only individual
cells stain positively for Mcm2 (arrows); (B,C) IF double labeling on
cryosections from resting uniparous WAP-T1 glands (120 days p.w.)
shows coincident labeling of TAg (red) and Mcm2 (green)
(B), respectively TAg (red) and Ki67 (green) (C); DNA staining with
DRAQ5 (blue) Bars: (A,B)=20µm.
The data indicate that alveolar differentiation marked by Elf5
also takes place in resting uniparous BALB/c glands and thus is
not a specific feature of resting uniparous WAP-T1 glands. But,
ELF5 expression in subpopulations enriched with differentiated
alveolar cells (CD61−/Sca1−) was significantly higher in WAP-T1
than in BALB/c mice. Furthermore, Sca1 negative subpopulations
from WAP-T, but not from BALB/c showed significant expression
of milk genes. This suggests that alveolar cells in resting uniparous
WAP-T1 glands (120 days p.w.) reach a more advanced stage of
differentiation marked by enhanced lactogenic activity.
TAg DOES NOT TARGET CK6a POSITIVE LUMINAL EPITHELIAL CELLS
Luminal epithelia of the mouse mammary gland contain CK6a
positive cells, which were repeatedly discussed to represent puta-
tive progenitor cells of the ductal and alveolar lineage (20, 37).
Furthermore, they were described as potential targets of activated
oncogenes in transgenic mice giving rise to mammary gland
tumors (22, 23). High grade tumors in WAP-T1 mice showed sig-
nificant expression of CK6 as assayed by gene expression analysis
(26). Thus, we asked whether TAg targets CK6a positive cells in
resting uniparous WAP-T1 glands.
IF studies on cryosections of resting uniparous WAP-T1 glands
indicated that CK6a positive cells are present in luminal epithelia
of ducts, but absent from hyperplasia composed of TAg positive
cells (Figure 8A).There was no evidence for CK6a positive cells
co-expressing TAg. In ducts, Ck6a positive luminal cells were often
seen in close proximity to TAg expressing cells (Figure 8B). These
data suggest that TAg does not target CK6a positive cells.
TAg EXPRESSING CELLS ARE ESTROGEN AND PROGESTERONE
RECEPTOR NEGATIVE
It is well-known that proliferation and differentiation of luminal
epithelia into lobulo-alveolar structures are under control of
hormone receptors (38–41). Thus, we asked whether high
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FIGURE 5 | qRT-PCR analysis of ELF5 and milk gene expression in
whole glands. ELF5 (A) and milk genes (CSN2, LALBA,WAP ) (B–D) are
expressed in resting glands (120 days p.w.) from BALB/c and WAP-T1
mice (n=10 from five mice); ELF5, (A), LALBA (C), and WAP (D) levels
are significantly higher in WAP-T1 than in BALB/c glands; individual
glands from lactating WAP-T1 mice (T1 Lak), WAP-T1 virgin mice (T1Vir),
and BALB/c virgin mice (Balbc vir) are included for comparison; data
presented as mean±SEM.
TAg levels in luminal cell subpopulations derived from rest-
ing uniparous WAP-T1 glands correlated with high expression
of either the estrogen (Esr1) or progesterone receptor (Pgr).
qRT-PCR analysis showed prominent Esr1 expression in Sca1+
subpopulations and a ~sevenfold lower expression in Sca1−
subpopulations from WAP-T1 (T1 in Figures 9A,B). A simi-
lar pattern was observed in subpopulations from resting uni-
parous BALB/c glands (BALB/c in Figures 9A,B). But, com-
pared to WAP-T1, Esr1 receptor expression was significantly
higher (1.6-fold, p< 0.01 for CD61+/Sca1+; twofold, p< 0.01 for
CD61−/Sca1+). Interestingly, WAP-T1 subpopulations with high
Esr1 levels showed low expression of TAg, Elf5, and milk genes
(compare with Figure 7), suggesting that TAg and estrogen recep-
tor mark different cells. In accordance by immunofluorescence, we
found no overlap between estrogen receptor (ER) and TAg staining
in luminal epithelia of glands (see Figure 10A).
Pgr expression levels in luminal cell subpopulations from
BALB/c glands generally exceeded those in subpopulations from
WAP-T1 glands (BALB/c and T1 in Figure 9B). Pgr levels were
most prominent in subpopulations enriched in CD61−/Sca1+
cells with a tendency to be higher (~twofold, n.s.) in BALB/c com-
pared to WAP-T1. Sca1− subpopulations of BALB/c and WAP-T1
mice exhibited strongly reduced expression levels of Pgr. Thus,
Pgr expression also shows a negative correlation with expression
of TAg, Elf5, and milk genes as observed for Esr1. In situ, proges-
terone (PR) positive cells were present in luminal epithelia of ducts
and generally showed no overlapping staining with antibodies to
TAg (Figures 10B,B′). Taken together, these data indicate that TAg
expressing luminal epithelial cells are estrogen and progesterone
receptor negative.
HORMONE RECEPTOR POSITIVE CELLS LOCALIZE TO DUCTAL
EPITHELIA AND EXPRESS CK6a, PROMININ-1, AND Sca1
Previous studies of others on adult virgin mice showed that
estrogen and progesterone receptor expression are confined to
“hormone sensing cells” located in the ductal epithelium; these
cells were shown to express prominin-1 (CD133) and Sca1 and
revealed a relatively differentiated phenotype (42). In line with
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FIGURE 6 | Sorting strategy for isolation of luminal epithelial cell
populations. After lineage depletion, basal, myoepithelial cells (CD29+) were
separated from luminal epithelial cells (CD29lo/−). Luminal epithelial cells were
separated into undifferentiated (CD61+) and differentiated (CD61−)
subpopulations and further separated into Sca1− and Sca1+ subpopulations
(A,B). (C) CK14, a marker of myoepithelial cells, is enriched in the basal
CD29hi subpopulation (n=5). (D) Sizes of subpopulations from BALB/c
(n=10) and WAP-T1 (n=23) mice as percent total cells; data presented as
mean±SEM. Population size of the CD61−/Sca1+ population was
significantly decreased in WAP-T1 mice compared to BALB/c (15.6 vs. 27.9%,
p<0.05) while CD61−/Sca1− population size was significantly increased (54.2
vs. 39.2%, p<0.05).
these data,our qRT-PCR analysis showed high expression of Prom1
specifically in the CD61−/Sca+ subpopulation both, from WAP-
T1 and BALB/c, and this population also exhibited high expres-
sion levels of Esr1 and Pgr (BALB/c and T1 in Figures 9C,D).
Krt6a expression was also most prominent in this subpopula-
tion. Therefore, we asked whether CK6a and prominin-1 localized
to identical epithelial cells. IF studies performed on cryosec-
tions of resting uniparous WAP-T1 glands demonstrated that
CD133 (prominin-1) and CK6a antibodies marked the same
cells in luminal epithelia of ducts (Figure 11A). CD133 positive
cells were also positive for the estrogen (Figure 11B), respec-
tively progesterone receptor (Figure 11C), but definitely neg-
ative for TAg. Our data indicate that CK6a, prominin-1, and
Sca1 are common markers of hormone receptor positive cells
in luminal epithelia of ducts. These cells proved to be absent
from hyperplasia in resting uniparous WAP-T1 glands, but in
ducts they often localized in close proximity to TAg expressing
cells.
RESTING GLANDS OF AGED WAP-T1 VIRGIN MICE ARE NOT
SENSITIZED TO ALVEOLOGENESIS
At this point, we asked whether WAP-T1 specific changes seen in
resting glands of parous animals are already pre-determined at
the virgin stage. We assumed that significant alterations should
accumulate with time and thus be most prominent in aged vir-
gin mice. Therefore, we extended our gene expression analysis to
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FIGURE 7 | qRT-PCR analysis of ELF5, milk gene (LALBA,WAP), and
TAg expression in luminal epithelial cell subpopulations from
resting (120days p.w.) glands of uniparous mice (BALB/c,T1) and
glands from virgin mice (BALB/c vir,T1 vir). ELF5 (A), LALBA
(B), WAP (C), and TAg (D) expression are most prominent in Sca1
negative cells; note equivalent ELF5 levels in undifferentiated
(CD61+Sca1−) cells of BALB/c and T1, but different levels in differentiated
(CD61−Sca1−) cells from both mouse strains; virgin mice show only
basal expression of ELF5 and milk genes (BALB/c n=4, T1 n=5, BALB/c
vir n=3, T1 vir n=3); ata presented as mean±SEM.
FIGURE 8 |TAg does not target CK6a positive luminal epithelial cells in
resting uniparousWAP-T1 glands. IF double labeling with antibodies to
CK6a (green) and TAg (red) on cryosections from resting uniparous WAP-T1
glands (120 days p.w.); DNA staining with DRAQ5 (blue); TAg positive
lesions lack CK6a positive cells (A); CK6a and TAg mark different luminal
epithelial cells in ductal compartments (A,B). Bars: (A)=30µm; (B)=5µm.
aged WAP-T1 and BALB/c virgin mice and isolated luminal cell
subpopulations at 160 days post-partum (p.p.). We combined the
qRT-PCR results shown in Figures 7 and 9 with the data obtained
with resting glands. qRT-PCR of aged virgin mice showed low
and nearly identical Elf5 levels in Sca1− subpopulations of both
strains (see BALB/c vir and T1 vir in Figure 7A).The milk genes
Wap and Lalba were barely expressed (see BALB/c vir and T1 vir
in Figure 7B). Esr1 and Pgr levels in luminal cell subpopulations
of aged virgins were virtually identical in both mouse strains (see
BALB/c vir and T1 vir in Figures 9A,B) and similar to the level in
resting (120 days p.w.) glands of normal BALB/c mice (see BALB/c
in Figures 9A,B). They reached the highest levels in CD61−/Sca1+
subpopulations, and like in resting glands these populations also
showed highest expression of Prom1 and Krt6a (BALB/c vir and
T1 vir in Figures 9C,D).
These results demonstrate that glands of aged virgin mice
display a hormone receptor status similar to that of resting
glands. However, pathways leading to expression of ELF5 and
milk genes seem not to be active at the virgin stage in both
mouse strains. Therefore, changes observed in resting uniparous
WAP-T1 glands are not already pre-determined in virgin mice.
The data indicate that passage through pregnancy, lactation, and
involution sensitizes luminal cell populations in resting glands of
parous BALB/c and WAP-T1 mice to pathways of alveologenesis.
DISCUSSION
Our data show that hyperplasia composed of TAg expressing
epithelial cells in resting uniparous WAP-T1 glands display fea-
tures of lobulo-alveolar cells. The cells not only express ELF5, a
transcription factor known to specify secretory alveolar cell fate
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FIGURE 9 | qRT-PCR analysis of hormone receptor, prominin-1, and
Ck6a expression in luminal cell subpopulations. Expression of the
estrogen receptor (ESR1) (A) and progesterone receptor (PGR) (B) in the
CD61−Sca1+ ductal cell subpopulation coincides with expression of
prominin-1 (PROM1) (C) and CK6a (KRT6A) (D); subpopulations from
virgin mice (BALB/c vir n=3; T1vir n=3); subpopulations from uniparous
mice 120 days p.w. (BALB/c n=4; T1 n= 5); data presented as
mean±SEM.
of CD61+ precursors in the mature alveolar epithelium (43, 44),
but are secretory as indicated by expression of milk genes. This
suggests they reach an advanced stage in alveolar differentiation.
As shown by immunofluorescence, TAg positive cells in lac-
tating WAP-T1 glands and in hyperplasia of resting uniparous
WAP-T1 glands did not express Sca1; Sca1 positive cells were
clearly confined to ductal epithelia. It suggests that Sca1 is a marker
which separates ductal cells from cells with an alveolar cell fate in
the mouse mammary gland. In accordance, ELF5 and milk gene
expression clearly separated with Sca1 negative subpopulations in
our RT-PCR analysis.
TAg was expressed at a high level not only in CD61−/Sca1−,
but also in CD61+/Sca1− cells. This led us to assume that TAg
targets luminal epithelial cells early during alveolar differentia-
tion. Possibly, TAg expression is initiated with the onset of ELF5
expression, as this master regulator of alveologenesis was shown
to induce WAP expression (43). Additional markers are needed to
precisely decipher alveolar differentiation of luminal cells in rela-
tion to TAg expression. Progress is being made in this area as a
recent study identified hitherto unknown epithelial cell lineages
that regulate spatial placement of tertiary branches as well as for-
mation of alveolar clusters in ducts of mammary glands (45). It
would be interesting to see if the onset of TAg expression coincides
with early priming to the alveolar lineage.
Elf5 expression was not only seen in resting uniparous WAP-T1
glands, but also in resting uniparous BALB/c glands. We show that
CD61+/Sca1− subpopulations from WAP-T1 and BALB/c glands
exhibited nearly identical, high levels of Elf5. Thus, alveologenesis
seen in resting WAP-T1 glands is not specifically induced by
TAg. Alveolar differentiation and formation of lobulo-alveolar
structures are initiated regularly in rodent mammary glands dur-
ing estrous cycle (46). Normally, these structures regress during
diestrus. Thus, we assume that development of hyperplasia in
WAP-T1 mice is initiated by mechanisms normally inducing tran-
sient alveologenesis in parous mice. Considering that ELF5 induces
the Wap promoter (43), it is conceivable that ELF5 sustains TAg
expression in differentiating alveolar cells. Although the cells show
lactogenic activity, they seem not to reach a terminal stage of alve-
olar differentiation, as they stay in cell cycle which is indicated by
positive reaction with antibodies to Mcm2 and Ki67. Both of these
markers are not expressed in differentiated cells (33, 34).
It has been well-established that differentiation into alveolar,
secretory active cells is regulated by a complex regulatory network
comprising hormone receptors and transcription factors (43, 44,
47, 48). Apparently, estrogen (ER) and progesterone receptor (PR)
positive cells compose a hormone sensing compartment within
the luminal epithelium of ducts that induces differentiation and
proliferation of hormone receptor negative cells through paracrine
mechanisms. In addition, proliferation of hormone sensitive cells
seems to be stimulated directly by progesterone and estrogen (42,
49). Recently, a relatively differentiated subpopulation of luminal
cells has been identified in glands of adult virgin mice displaying
the markers CD24high/Sca1+/prominin-1+(CD133)/CK18+ and
expressing estrogen, progesterone, and prolactin receptors. These
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FIGURE 10 |TAg positive epithelia in resting uniparousWAP-T1 glands
are negative for estrogen receptor (ER) and progesterone receptor
(PR). (A–B′): IF double labeling on cryosections from resting uniparous
WAP-T1 glands; (A) Double labeling with antibodies to estrogen receptor
(ER) (green) and TAg (red); staining of DNA with DAPI (blue); ER positive
cells are TAg negative [arrows in (A)]; (B,B′): double labeling with antibodies
to progesterone receptor (PR) (green) and TAg (red); DNA staining with
DAPI (blue); note the high number of PR positive but TAg negative cells in
epithelia of ducts; no coincident labeling of PR [arrows in (B)] and TAg. Bars:
(A)=20µm; (B,B′)=50µm.
cells represent little stem cell activity and show no proliferative
activity, suggesting they constitute a hormone sensitive compart-
ment (42). Here, we demonstrate for WAP-T1 glands that these
cells localize to luminal epithelia of ducts, are TAg negative, but
in close proximity to TAg positive cells. Furthermore, we show for
the first time that ductal cells positive for hormone receptors and
prominin-1 (CD133) are identical with those expressing cytok-
eratin CK6a. CK6a has been discussed to mark a population of
luminal mammary progenitor cells (30, 50, 51), which lack repop-
ulation activity (37). A progenitor cell function is compatible with
FIGURE 11 | CK6a marks CD133 (prominin-1) and hormone receptor
positive cells in luminal epithelia ofWAP-T1 glands. (A–C) IF double
labeling on cryosections of resting uniparous WAP-T1 glands (120 days
p.w.); DNA staining with DAPI (blue); (A) Coincident staining of luminal
epithelial cells in ducts with antibodies to CD133 (green) and CK6 (red);
(B) Coincident labeling of luminal cells with antibodies to CD133 (green)
and estrogen receptor (red); (C) Coincident staining of luminal epithelial
cells with antibodies to CD133 and progesterone receptor (PR); note the
cap-like staining of CD133 at the luminal side of epithelial cells in
(A–C). Bars: (A)=20µm; (B,C)=50µm.
changes in the relative proportion of cells during mammary gland
development. These cells are found at significant quantity in mam-
mary ducts of virgin mice, reduced in number during pregnancy,
www.frontiersin.org June 2014 | Volume 4 | Article 168 | 11
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quante et al. Hyperplasia in WAP-T1 mice
apparently absent from epithelia of lactating glands, and reappear
in resting glands after involution (37).
Our qRT-PCR data further corroborate a relationship between
expression of CK6a, prominin-1, and hormone receptor genes.
Prom1 and Krt6a expression were prominent in the same Sca1
positive subpopulation of luminal cells. This subpopulation also
proved to be unique with regard to expression of the progesterone
receptor, a hormone receptor known to drive mammary secre-
tory differentiation via induction of ELF5 in luminal progenitors
(47). Thus, we speculate that CK6a+/prominin+/Sca1+/ER+/PR+
luminal cells have a unique function in induction of TAg and ELF5
leading to the formation of TAg positive, estrogen, and proges-
terone receptor negative hyperplasia. Crossing of WAP-T1 mice
with conditional progesterone receptor knock-out mice would be
an interesting approach to investigate this hypothesis by testing for
the requirement of this hormone receptor for tumor formation.
Features described here for WAP-T1 mice may also apply
to other transgenic mouse models of mammary carcinogene-
sis that display hyperplasia with an alveolar phenotype. Similar
to WAP-T1, C3(1)/SV40-T transgenic mice showed TAg expres-
sion in terminal duct lobular units (TDLU), an increased number
of TDLU proliferative lesions and side ducts, and at later stages
expansion of cells into the ductal lumen with multistage progres-
sion to carcinoma (52). Mice transgenic for the polyomavirus mid-
dle T-antigen (PyV-mT) under control of the MMTV promoter
showed focal pre-malignant lesions and an enhanced number of
abortive side buds with lumen that was positive for milk proteins
(WAP and OPN) (53). Mice transgenic for Wnt-1, Int-2, Cyclin D,
or TGFα under control of mammary specific promoters (MMTV,
WAP, ß-lactoglobulin) also developed alveolar hyperplasia (54–
56). In MMTV-neu transgenic mice, parity induced epithelial cells
endowed with the potential to differentiate into alveolar or duc-
tal cells were identified as targets for induction of tumorigenesis
(24). Thus, hormone dependent activation of an oncogene in dif-
ferentiating luminal epithelial cells of the mammary gland could
generally be a crucial step to induction of aberrant proliferative
activity leading to the formation of hyperplastic lesions.
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